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Abstract
In response to a need for improved treatments, a number of promising novel targeted cancer
therapies are being developed that exploit human synthetic lethal interactions. This is facili-
tating personalised medicine strategies in cancers where specific tumour suppressors have
become inactivated. Mainly due to the constraints of the experimental procedures, relatively
few human synthetic lethal interactions have been identified. Here we describe SLant (Syn-
thetic Lethal analysis via Network topology), a computational systems approach to predict-
ing human synthetic lethal interactions that works by identifying and exploiting conserved
patterns in protein interaction network topology both within and across species. SLant out-
performs previous attempts to classify human SSL interactions and experimental validation
of the models predictions suggests it may provide useful guidance for future SSL screenings
and ultimately aid targeted cancer therapy development.
Author summary
Our new algorithm SLant, uses artificial intelligence to help target future cancer drug
research. In healthy cells tens of thousands of proteins work together forming large inter-
action networks. However, in cancerous cells genetic damage means that many of these
proteins are disabled. Basic functions like DNA repair and signaling no longer work prop-
erly, and the cell replicates without proper control. Recent experience with breast cancer
shows that gentler, more personalised therapies can be achieved by finding pairs of pro-
teins which are ‘synthetically lethal’. The term means that the cell can cope if either one of
the proteins does not work, but will die if neither of the proteins is functioning. Many syn-
thetic lethal interactions are known, but there are many millions of potential pairs and
finding new ones experimentally is difficult and time-consuming. SLant uses most of the
experimental data that we have to identify the patterns in the protein interaction network
associated with being part of a synthetic lethal interaction. By searching the network for
proteins pairs that match these patterns, it can effectively predict new synthetic lethal
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Introduction
Despite sustained global efforts to develop effective therapies, cancer is now responsible for
more than 15% of the world’s annual deaths. There are over 12 million newly diagnosed cases
per annum and this figure continues to grow [1]. Standard chemotherapy involves non-selec-
tive, cytotoxic agents that often have limited effectiveness and strong side-effects. Conse-
quently, the current focus in oncology drug discovery has moved towards identifying targeted
therapies that promise both improved efficacy and therapeutic selectivity [2].
The development of multi-platform genomic technologies has enabled the identification of
many of the genes that drive cancer [3]. These cancer driver genes can be broadly classified
either as oncogenes or tumour suppressors. The protein product of an oncogene shows an
increase in activity, or a change or gain of function when mutated, whereas mutations or epi-
genetic silencing in tumor suppressors result in an inactivation or loss of function (LOF) of the
protein product [4].
Targeted therapies that act on oncogenes often work by directly inhibiting the activated
protein product. This strategy has been particularly successful for targeting nuclear receptor
proteins or those that contain protein kinase domains. [5–7]. Unfortunately, it is not usually
feasible to repair tumour suppressor genes or their protein products, particularly if they are
inactivated by a truncation [8]. Instead an emerging strategy is to target tumour suppressors
indirectly by exploiting synthetic lethal interactions.
Synthetic lethality (SSL) is a phenomenon whereby individual genes in a pair can be
knocked-out without affecting cell viability, whilst disruptions in both genes concurrently
cause cell death [9]. Synthetic sensitive and synthetic sickness interactions are extensions of
this concept where concurrent genetic interactions impair cellular fitness without necessarily
killing the cell. Conversely, synthetic dosage lethality (SDL) interactions occur when over-
expression of one gene, in combination with loss of function in another gene results in cell
death. SSL and SDL interactions are both examples of negative genetic interactions. Negative
genetic interactions are events where a deviation from the expected phenotype is observed
when genetic mutations occur in more than one gene [10].
To exploit SSL interactions therapeutically one gene, the tumour suppressor, is genetically
inactivated by mutation while the protein product of the other is targeted and inactivated
pharmacologically [11]. Synthetic dosage lethal interactions can be used for targeting cancer
cells with over-expressed, undruggable oncogenes [11]. SDL causes cell death as a result of one
gene being genetically activated (GOF, the oncogene) and another being inactivated (LOF, the
drug target).
PARP inhibitors are the most developed therapies that exploit SSL interactions. The PARP
inhibitor Olaparib, has been approved for the treatment of patients with recurrent, platinum-
sensitive, high-grade serous ovarian cancer with BRCA1 or BRCA2 mutations [12, 13]. PARP1
(poly(ADP-ribose) polymerase) is an important component in DNA single strand break repair
and has been shown to share a synthetic lethal relationship with both BRCA1 and BRCA2 [14,
15], which are themselves both key in DNA double strand break repair. Complete loss of func-
tion of the protein product of either BRCA gene leaves cells extremely sensitive to PARP inhib-
itors presenting this therapeutic opportunity [16, 17].
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Other studies have highlighted a range of SSL interactions that may provide suitable targets
for therapy [18–20]. For example, PI5P4K kinases are essential in the absence of p53 [21], inhi-
bition of ENO2 inhibits viability in ENO1 deficient glioblastoma cells [22] and APE1 inhibi-
tors in PTEN deficient cells results in the induction of apoptosis [23].
Currently, mainly due to experimental limitations [24] exhaustive experimental identifica-
tion of human SSL interactions is not tenable. However there are many studies focused on
screening for genetic interactions in model organisms [25]. Unfortunately, genetic interactions
are not highly conserved between lower eukaryotes and their human orthologue equivalents
[26]. Instead, in order to identify novel human SSL interactions, we are left to infer and predict
these pairs indirectly from existing human and model organism data through the use of mod-
els and other computational techniques [27].
Several classifiers have been developed to predict genetic interactions within model organ-
isms. Wong et al. [28] predicted genetic interactions in Saccharomyces cerevisiae using decision
tree classifiers with multiple data types and network topology. Paladugu et al. [29] focused on
S. cerevisiae data; by extracting multiple features from protein interaction networks they
achieved sensitivity and specificity exceeding 85% using support vector machine (SVM) classi-
fiers. Later, Chipman et al. [30] employed random walks and decision tree classifiers on pro-
tein interaction and gene ontology (GO) data to classify both S. cerevisiae and C. elegans
negative genetic interactions.
Several classifiers have been developed to predict genetic interactions between species.
Zhong and Sternberg [31] classified Caenorhabditis elegans negative genetic interactions based
on orthologous gene pairs in S. cerevisiae and Drosophila melanogaster. Jacunski et al. [32]
developed SINaTRA (Species-INdependent TRAnslation) to classify S. cerevisiae SSL pairs
based on Schizosaccharomyces pombe training data and vice versa, using features extracted
from physical interaction data. The model trained on S. cerevisiae data was applied to predict
1,309 human SSL pairs with a reported false positive rate of 0.36. Similarly Wu et al [33] devel-
oped MetaSL, an ensemble machine learning mode which applied eight different classifiers on
S. cerevisiae data and applied it to predict human SSL pairs.
Using an alternative approach, the DAISY workflow predicted human SSL interactions
directly from human cancer and cell–line data [34]. The authors used somatic copy number
variation and mutation profiles to achieve a ROC AUC score of 0.779 demonstrating a strong
propensity (p-value < 1e-4) for predicting SSL pairs in H. sapiens.
There are a number of additional recent studies that use biological networks to predict
genetic interactions. Mashup [35] reported an average area under the precision curve (AUPR)
of 0.59 for SSL and 0.51 for SDL pair prediction in a real human dataset. Others have utilised
gene ontology terms to predict SSLs. These include Ontotype [36], where the authors predict
the growth outcome on double knock-out of gene pairs. Their prediction set of gene pairs
related to DNA repair and nuclear lumen correlated with Costanzo et al’s [37] validated SSL
dataset with a coefficient of r = 0.61. The authors of DCell [38] constructed a visible neural net-
work embedded in the hierarchical structure of 2526 subsystems describing the eukaryotic cell
and used this to predict negative genetic interactions in S. cerevisiae.
In this study we introduce SLant (Synthetic Lethal analysis via Network topology), a ran-
dom forest classifier trained on features extracted from the protein-protein interaction (PPI)
networks of five species. These features comprise both node-wise distance and pairwise topo-
logical PPI network parameters and gene ontology data. Using SLant we provide in-species,
cross-species and consensus classification for synthetic lethal pairs in all five organisms includ-
ing human. We subsequently experimentally validated three of the predicted human SSLs in a
human cell-line. Finally we identify a large cohort of candidate human synthetic lethal pairs
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which are available with the consensus predictions for all the model organisms in the Slorth
database (http://slorth.biochem.sussex.ac.uk).
Results
A genome-wide protein-protein interaction (PPI) network was constructed for Homo sapiens
and each of our model organisms (S. cerevisiae, D. melanogaster, C. elegans, and S. pombe)
using PPI data from the STRING database [39]. In this network, each node represents a pro-
tein and each edge represents a physical interaction between two proteins. For each pair of
proteins 12 node-wise and 7 pairwise features were extracted from the PPI network using the
R igraph library [40]. Each protein in the network was labelled with its respective Ensembl
gene identifier so that this physical interaction data could be matched with gene interaction
data. For each gene pair 3 additional GO term related features were generated using Gene
ontology (GO) data [41].
For each PPI network, pairs of proteins whose respective genes were identified as having a
negative genetic interaction in BioGRID [42] were labelled as having an SSL interaction (Fig
1). Equal numbers of SSL and non-SSL gene pairs were selected independently for the training
sets for each species (see methods). Similarly we created training sets for SDL and non-SDL
gene pairs in H. sapiens and S. cerevisiae, the only two species where there is enough data for
prediction purposes.
Network parameter distributions in humans
The features used for classification in the SLant algorithm were broadly divided into node-
wise, pairwise or GO-term related categories. Node-wise features were derived from an indi-
vidual node’s network parameter, such as degree or centrality. These node-wise features were
converted to pairwise features by taking the average distance for that feature between the
nodes in each pair. Pairwise features were defined as those that apply to a pair of nodes such as
shortest path or cohesion. The spin glass random walk features discussed below were included
in our pairwise category. GO related features were derived from shared annotations between
pairs of genes [41] (for a full list of features see Table 1).
Fig 2 shows the distribution of these features in SSL and non-SSL gene pairs in humans. In
general pairwise parameters showed a greater variance between SSL and non-SSL classes than
our node-wise parameters suggesting they may prove better predictors in our models. Of these
pairwise parameters the most notable differences were observed in the parameters labelled:
cohesion—the minimum number of nodes that would have to be removed to result in two sep-
arate sub-graphs separating the source and target nodes, shortest path—the minimum number
of nodes that must be traversed in a path between the source and target gene, and mutual
neighbours—the number of nodes that are shared as neighbours between the source and target
gene.
The higher values exhibited by gene pairs in the SSL class for the cohesion feature (paired t-
test; p = 2.2e-16 in H. sapiens) suggest that SSL pairs are generally more densely connected in a
physical interaction graph than non-SSL pairs (S1A Fig).
We also note that the shortest path between gene pairs is shorter on average for SSL gene
pairs compared to non-SSL gene pairs (paired t-test; p = 4.589e-11 in H. sapiens) (S1B Fig)
and, related to the shortest path parameter, SSL genes more often share a large number of
mutual neighbours (paired t-test; p = 4.058e-11 in H. sapiens) (S1C Fig).
In terms of node-wise features it is of some interest to note that the difference between
neighbourhood sizes of two genes in an SSL pair often differ more than those in a non-SSL
pair.
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Random walk community generation suggests that most SSL interactions
occur between rather than within clusters of genes
In an attempt to ascertain whether synthetic lethal interactions occurred within or between
local clusters of genes in our physical interaction network we applied a spin-glass random walk
to assign genes to 20 distinct communities separated by choke points across the graph (Fig
3A). Analysis showed that the majority of SSL interactions occurred between these communi-
ties rather than within (Fig 3B). In addition pairwise topological analysis suggests that SSL
pairs of genes have shorter paths between them than non-SSL pairs and a higher occurrence of
adjacency. Together these analyses suggest that SSL pairs are often at the peripheries of these
communities, connecting their respective clusters.
Fig 1. A schematic visualising how SLant’s source data is collated from STRING and the Gene Ontology Consortium, preprocessed so that this source
data can be directed joined with BioGRID data for labeling and processed to create the final training set. Feature generation was completed using R, the R
igraph library and GoSemSim, a Bioconductor package.
https://doi.org/10.1371/journal.pcbi.1006888.g001
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Based on these observations we were able to create two additional features which provide
further predictive power for classifying SSL pairs; whether nodes shared a community and
whether the pair connected two communities.
SSL pairs shared more GO annotations than non-SSL pairs
The count of shared GO terms, that is the number of GO annotations that two genes in a pair
share with each other, also varies between SSL and non-SSL observations. SSL pairs generally
share, on average, less biological process GO annotations (S1 Table) than non-SSL pairs
(p< 2.2e-16 in H. sapiens) and proportionately more molecular function and cellular compo-
nent GO annotations (p< 2.2e-16 in H. sapiens for both biological process and cellular com-
partment terms). This supports the view that that SSL protein product pairs are often found in
similar but distinct pathways rather than within a single pathway [43]. Damaging two
Table 1. Names and descriptions of the node-wise and pairwise network parameters and GO term features used
in Slant.
Name Class Description
Betweenness Node-
wise
The number of shortest paths in the entire graph that pass through the
node.
Constraint Node-
wise
Related to ego networks. A measure of how much a node’s connections
are focused on single cluster of neighbours.
Closeness Node-
wise
The number of steps required to reach all other nodes from a given
node.
Coreness Node-
wise
Whether a node is part of the k-core of the full graph, the k-core being a
maximal sub-graph in which each node has at least degree k.
Degree Node-
wise
The number of edges coming in to or out of the node.
Eccentricity Node-
wise
The shortest path distance from the node farthest from the given node.
Eigen centrality Node-
wise
A measure of how well connected a given node is to other well-
connected nodes.
Hub score Node-
wise
Related to the concepts of hubs and authorities the hub score is a
measure of how many well linked hubs the nodes is linked to.
Neighbourhood n size Node-
wise
The number of nodes within n steps of a given node for n of 1, 2, 5 and
6
Adhesion Pairwise The minimum number of edges that would have to be severed to result
in two separate sub-graphs separating the source and target nodes.
Cohesion Pairwise The minimum number of nodes that would have to be removed to
result in two separate sub-graphs separating the source and target
nodes.
Adjacent Pairwise Whether a source and target node are connected via an edge.
Mutual neighbours Pairwise How many first neighbours a target and source node share.
Shortest path Pairwise The minimal number of connected vertices that create a path between
the source and target node.
Between community Pairwise A logical feature stating whether the source and target nodes inhabit the
same community produced by the spin glass random walk.
Cross community Pairwise A logical feature stating whether the source and target nodes connect
two communities as produced by the spin glass random walk.
Shared GO count–Biological
process
Go term The number of biological process GO annotations shared between the
source and target node.
Shared GO count–Molecular
function
Go term The number of molecular function GO annotations shared between the
source and target node.
Shared GO count–Cellular
compartment
Go term The number of cellular compartment GO annotations shared between
the source and target node.
https://doi.org/10.1371/journal.pcbi.1006888.t001
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complementary functional pathways is likely cause more stress to the cell than damaging one
pathway twice and leaving the complementary pathway functional.
Although the GO annotation based features above provide predictive power in our models
as discussed below, due to the hierarchical nature of GO annotation, comparing the absolute
count of shared GO terms does present some issues. As such GoSemSim [44] was used to fur-
ther measure the semantic similarity between SSL and non-SSL pairs. We found that in H.
sapiens SSL pairs showed a significantly higher semantic similarity score (mean = 0.65) that
non-SSL pairs (mean = 0.57) (Welch two sample t-test p = 4.6e-07).
Analysis of GO terms present in paired SSL genes found that the most commonly shared
molecular functional GO annotation related to protein binding (S2 Fig). Other molecular
function GO annotations commonly found associated between SSL pairs include protein com-
plex binding, GTP binding, DNA binding and GTPase activity. At the level of biological pro-
cess GO annotation for SSL gene pairs we also noted associations with terms related to
positive regulation of cell proliferation and negative regulation of apoptotic process as well as
Fig 2. A set of violin plots illustrating the value distributions for each feature in our human training set grouped into SSL and non-SSL classes. The
features were derived from 411 SSL and 411 non-SSL gene pairs (see S6 Table). Feature distributions that show greater variance between SSL and non-SSL gene
pair classes, for example the shortest path feature, often provide improved predictive power in classifiers.
https://doi.org/10.1371/journal.pcbi.1006888.g002
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Fig 3. a. Human protein-protein interaction network with clustered communities generated by a spin glass random
walk. Nodes and edges are coloured by their source community cluster as per the legend provided in Fig 3B. b.
Community cluster connection graph where the weight of each connection corresponds to how many SSL interacting
pairs begin and end at each community. We observe the largest count of SSL interactions occurring between cluster 9,
notably associated with transcription regulation and DNA damage response GO terms and cluster 15, associated with
MAPK cascade, cell proliferation and gene expression GO terms.
https://doi.org/10.1371/journal.pcbi.1006888.g003
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those labelled with positive regulation of gene expression and positive regulation of transcrip-
tion from RNA polymerase II promoter.
In an attempt to further quantify the GO annotation driving the variation between genes
found in SSL pairs and those not found in SSL pairs we employed a GO enrichment analysis
using the on-line GOrrila tool [45]. We found significant enrichment in a number of GO
annotations including negative regulation of cell differentiation (p = 9.15e-3), positive regula-
tion of transcription by RNA polymerase II (p = 9.53e-3) and regulation of Notch signaling
pathway (p = 8.85e-3) in the biological process ontology but no further enrichment in the
molecular function or cellular compartments ontologies. All p-values have been are corrected
for false positives using the Benjamini Hochberg method.
SSL interactions in essential genes
Comprehensive studies of S. cerevisiae genetic interactions by Costanzo et al [37, 46] have
found that essential genes that share an edge on the PPI network are enriched for genetic inter-
actions and that is consistent with previous observations [43]. As our classifiers in part use the
distance of gene pairs as a predictive feature we performed analysis to ensure our predictions
were not simply picking out gene pairs enriched for essential genes.
We first noted that the range of shortest path values between SSL pairs on the protein-pro-
tein interaction (PPI) network runs from 1 to 7 with a mean of 2.43 and a standard deviation
of 0.78 affirming that our training set features many SSL pairs that are not adjacent in the PPI
network.
Using a set of essential human genes defined by Wang et al. [47], we found that 11% of the
genes in our SSL training set were defined as essential, where as for non-SSL genes it only
0.7%. For human gene pairs ~1.7% of SSL pairs and ~1.4% of non-SSL pairs are comprised of
two essential genes. We also found that 29% of SSL pairs and 22% of non-SSL pairs included at
least one essential gene.
Upon comparison we found that ~22.5% of our SSL predictions included at least one essen-
tial gene and ~1.4% featured two essential genes, a ratio comparable with our training data.
This suggests that our predictions are not further enriched for essential genes.
Models explaining patterns of genetic interactions. There are three models used to
explain how genetic interactions occur [43, 48, 49]. The “between pathway model” is where
the genetic interaction involves genes in two distinct pathways with complementary functions.
A deletion of a gene in one pathway abrogates the function of that pathway and the cell cannot
survive with of both pathways are lost. The “within a pathway model” is where genetic interac-
tion occurs between genes in the subunits of a single pathway. Loss of one gene can be toler-
ated but the additive effects of the loss of several genes in that pathway are lethal. Finally ’the
indirect model’ is where the phenotype is not mediated by a localised mechanism.
Previous computational analyses have found that negative genetic interactions are enriched
both between biological processes (or pathways) and within biological processes, giving cre-
dence to these models [37, 43, 46, 50]. SSL interactions occur primarily between local clusters
in the PPI network suggest that the between pathways interactions may still involve pathways
that are close in PPI space. This may explain why the analysis of PPIs is so effective in predict-
ing SSL interactions.
Network parameter distributions in model organisms
The distribution of network parameters across our four model organisms widely followed sim-
ilar trends with our human feature set. Again the pairwise features for each organism appear
to vary more between SSL and non-SSL classes than node-wise features. A few dissimilarities
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were noticeable, for example while SSL gene pairs tend to exhibit a higher levels of adhesion
and cohesion in H. sapiens, S. cerevisiae (S3A Fig) and D. melanogaster (S3B Fig) the distribu-
tion for these features were notably inverted in C. elegans (S3C Fig) and S. pombe (S3D Fig) so
that non-SSL pairs showed higher adhesion and cohesion than SSL pairs.
Validating SSL gene pair classification
In this study we perform two classifications. First in-species classification, classifying and vali-
dating SSL gene pairs using training and test data from the same organism. Then cross-species
classification where we use the models built using the training data for each organism to
blindly predict SSL for each other species. Within each species, the feature data were normal-
ised and segmented into training and test sets with 20% set aside for validation. We employed
5-fold cross validation to optimise the hyperparameters for each organism’s random forest
classifier and evaluated in-species classification performance (Table 2). In this study our ran-
dom forest classifiers utilised just one hyper-parameter, mtry—the number of variables ran-
domly sampled as candidates at each split for each tree. The best classifier for each species was
then used to predict the SSL gene pairs in each of the other four species. Table 2 shows the
ROC AUC scores for both the in-species and cross-species predictions for all of our models.
Although it is difficult to compare the performance of classifiers due to varied validation
sets, the ROC AUC score of 0.965 for H. sapiens SSL gene pair classification achieved by the
SLant classifier (using holdout validation data) appears to out-perform Daisy’s ROC AUC
score of 0.779.
Our initial in-species classification of S. cerevisiae SSL resulted in relatively low perfor-
mance (AUC 0.734) compared to other related studies. For example MetaSL, which used a
much smaller data set of just 7,347 SSL pairs compared to Slant’s 395,199 pairs, achieved ROC
AUC scores of up to 0.871 [33]. In order to mitigate any noise or error introduced in our large
dataset we filtered out any SSL interactions reported in BioGRID supported by less than 3 sup-
porting publications for S. cerevisiae and less than 2 papers for S. Pombe. Our training data
ultimately used 17,568 out of a total 395,199 SSL pairs available for S. cerevisiae and 3,836 out
of 35,391 SSL pairs for S. Pombe. These sample sizes should still be large enough to generalise
well for out of sample predictions as well as preforming well in classification and validation.
Filtering our yeast data improved our scores from AUC ROC 0.734 to AUC ROC 0.883 for S.
cerevisiae and 0.728 to 0.889 for S. Pombe which suggests that by removing pairs that show
fewer citations in the BioGRID data we are reducing variation in our training data introduced
by false positives. This may be due to the relatively high false-positive rate found in large scale
GI screenings, an observation supported by analysis performed by Campbell & Ryan et al. who
Table 2. Cross validation ROC AUC scores for each organism from both in-species and cross species SSL models. The best score for each species model is highlighted
in green. Models are displayed vertically in rows with the consensus model displayed at the bottom of the table and the results for those models are displayed in columns
with the consensus results highlighted in blue.
Validation results
H.
sapiens
S.
cerevisiae
C.
elegans
D.
melanogaster
S.
pombe
Model H. sapiens 0.965 0.698 0.662 0.687 0.661
S. cerevisiae 0.713 0.883 0.694 0.784 0.717
C. elegans 0.769 0.598 0.979 0.744 0.588
D. melanogaster 0.727 0.790 0.816 0.906 0.778
S. pombe 0.48 0.607 0.574 0.660 0.889
Consensus 0.985 0.907 0.982 0.903 0.920
https://doi.org/10.1371/journal.pcbi.1006888.t002
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estimated that large scale screenings can suffer a false positive rate of up to ~10% [51]. Using
this value we can calculate that by removing GI pairs with less than 2 and 3 references respec-
tively we may be reducing false positive rates from 1/10 to 1/100 in S. pombe and from 1/10 to
1/1000 in S. cerevisiae.
Cross-species predictions of SSLs were quite variable in performance. Models from both S.
cerevisiae and D. melanogaster and C.elegans were successful in predicting human SSLs with
AUC ROC scores of 0.713, 0.727 and 0.769 respectively.
Although the C. elegans classifier performed relatively poorly in our cross-species validation
for H. sapiens classification, this variation may help improve the generalisation of our consen-
sus model which is discussed below. To test this cross-species validation was performed with-
out the worm model. The removal of worm data from the classifier resulted in a small but
noticeable decrease in performance of the consensus classifier for humans (decreasing from
~0.985 to ~0.92).
The result here suggest that the PPI patterns between SSL genes are similar both within and
between species and that network topology features used in our classifiers generalise well
across organisms. We identified the most predictive features for each organism and found that
the same features were most predictive in many of the species. The shared GO count features
were important in all organisms except S. pombe and the pairwise features adhesion, cohesion,
mutual neighbours and adjacency were important in all organisms except C. elegans. Two
node-wise features, coreness and neighbourhood size are also listed as important features
across 3 organisms (S2 Table).
Class balance changes do not significantly impact classifier performance
As described below in methods each of these models use a balanced training set with a ratio
of 1:1 interacting and non-interacting pairs, however in reality the ratio between interacting
and non-interacting pairs is likely more in the order of 1:50 based on global yeast GI screens
[37]. To ascertain that our class balance has not unduly biased our prediction in any way we
re-ran our classifiers using a randomised training / validation set with approximately 1:10
and 1:50 class balance. We found that with a class balance of 1:10 our performance
remained stable and with a class balance of 1:50 we found just a small drop in performance
(human AUC ROC ~0.87 compared to the original ~0.965 and consensus AUC ROC ~0.90
compared to ~0.985).
Our models are robust to incompleteness in the source PPI networks
It is known that our current PPI models are incomplete [52–54] and suffer from ascertain-
ment bias. That is, some genes, and indeed some species, are better studied than others. To
test our model’s robustness to the incomplete nature of the protein-protein interaction net-
works, we re-ran our classifiers holding out 10% and 20% of the nodes, at random, from
original PPI data in H. sapiens. In the case of the 90% ‘complete’ PPI network the perfor-
mance of our in-species model validation was not effected and our H. sapiens consensus
showed just a small drop in performance (from AUC ROC ~0.985 to ~0.922). With a 80%
‘complete’ H. sapiens PPI network we saw another fairly small incremental drop in H. sapi-
ens consensus performance (AUC ROC ~ 0.85) and a small drop in H. sapiens in-species
performance (AUC ROC dropping from 0.965 to 0.911). This suggests both that an increas-
ingly complete PPI network may incrementally improve our predictive performance and
that the current models are fairly resilient to the incomplete nature of the PPI network.
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Our pair-wise distance features are the most predictive
In addition to the feature importance analysis performed in this study we also re-ran our clas-
sifiers holding out our 12 node-wise distance features, 6 pair-wise features and 3 GO-term
related features in turn. We found that the model holding out pair-wise features saw the largest
drop in performance in consensus with the H. sapiens consensus ROC AUC dropping from
~0.985 to ~0.730 and the in-species H.sapiens ROC AUC dropping from ~0.965 to ~0.82. In
comparison to our models holding out node-wise features saw a more notable drop in the in-
species performance (H.sapiens consensus ROC AUC dropping from ~0.985 to ~0.85 and in-
species H.sapiens from ~0.965 to ~0.823). Similarly holding out our GO term features resulted
in a decrease in predictive performance (H.sapiens consensus ROC AUC dropping from
~0.985 to ~0.882 and in-species H.sapiens from ~0.965 to ~0.890).
Our models are moderately robust to pair-input bias
As discussed by Parks et al. [55] computational prediction methods that utilise gene pair obser-
vations, such as the models in this study, can be subject to positive bias in validation. They dis-
covered that model validation performed significantly better when genes that made up the
pairs in the test set were also featured in the training set compared to those models where they
were not.
In order to evaluate how SLant’s validation was effected by pair-input bias we generated
a test set from our raw feature data in which none of the genes featured in the test pairs
were present in any of the pairs featured in the training set. We refer to these as segregated
datasets.
To make sure we could make a fair comparison we generated a further control training and
test set by randomly sampling the pairs created above from both segregated data sets. This
ensured that the pair count and the pairs themselves remained the same while gene compo-
nents could be shared between our control training and test sets.
Running our models again using these segregated training and test data we achieved a
AUC ROC of 0.789 for predicting human SSL pairs, compared to 0.845 for our control data-
sets and 0.965 for our full training and test sets. This suggests that while our predictions
may be somewhat biased towards genes that are featured in the training data our models
also appear to predict SSL pairs comprised of genes that are not in our training data and,
more importantly, potentially genes that have not previously been associated with SSL
interactions.
A consensus based on many cross-species predictions further improves
performance
To further expand our model we took a consensus from the cross-species predictions for each
organism. This consensus was calculated by running a second classifier, a boosted general lin-
ear model (GLM) that was trained on the previous cross-species classifier output. This output
took the form of confidence scores. For example, for any particular pair of human genes the
confidence scores given to that pair by every cross-species classifier were used as features. The
probability outputted by this final classifier is referred to as the consensus score.
To allow for validation this consensus dataset was segmented into a training and test set
(both 0.5 the size of the original due to the smaller overall size). The ROC AUC for our consen-
sus prediction validation was also plotted and achieved a score of up to 0.985 when predicting
H. sapiens SSL pairs, a further improvement on our in-species human validation ROC AUC
score of 0.965 (Fig 4).
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Predicting synthetic dosage lethal pairs
To ascertain whether SSL and synthetic dosage lethality (SDL) interactions share topological
predictors we re-purposed our models to predict SDL gene pairs. We achieved an in-species
AUC of 0.78 for H. sapiens pairs and 0.89 for S. cerevisiae pairs, a significantly improved score
compared to that achieved during S. cerevisiae SSL pair classification. Our consensus model,
utilising just H. sapiens and S. cerevisiae data, improved our H. sapiens predictions slightly
(ROC AUC 0.80) (S3 Table).
Fig 4. Cross-species ROC AUC scores for each models classification performance on our human SSL interaction validation set. An additional curve for
our consensus predictions was added separately based on the performance of the consensus validation set.
https://doi.org/10.1371/journal.pcbi.1006888.g004
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SDL and SSL pairs in H. sapiens exhibit broadly similar feature distribution and feature
importance for both classifiers. Despite this only 7,531 pairs were predicted as both SDL and
SSL (of 41,103 SDL pair predictions and 59,475 SSL pair predictions).
In our human SDL models cohesion and shared cellular compartment GO terms featured
as important features for both classifiers though molecular functional GO term annotation
proved an important feature for SDL classification while shared biological process GO term
featured well for SSL classification. The closeness feature, which measures how many steps is
required to reach all other nodes from a given node, performed well for SDL classification. On
the other hand coreness, a measurement of how well connected a node’s neighbours are com-
pared to the graph overall provided better predictive power for SSL classification.
We next compared biological process GO terms present in SDL and SSL pairs. We found
that DNA damage related processes were more frequently seen in SDL pair data than in SSL
pair data (~1.00% cellular response to DNA damage stimulus, ~0.70% DNA repair in SDL
pairs compared to ~0.53% and ~0.46% respectively in SSL pairs). MAPK cascade and regula-
tion of cell proliferation processes were well represented in both groups.
Comparison to previous studies
As discussed in the introduction, a number of other studies have used similar methods to pre-
dict genetic interactions. Most notably, this study shares a number of similarities with SINa-
TRA [32]. However, SLant has been developed for a wider number of organisms, including
using human data directly, uses an enhanced feature set, our predictions have been experimen-
tally validated (see below) and all of our data are available via the SLorth database (see below).
Algorithmically, the similarities between SLant and SINaTRA include some of the features
used and the treatment of normalisation to allow cross-species prediction. However the PPI
data used by SLant were sourced from STRING and were filtered for reliability, while SINa-
TRA’s PPI data were sourced from BioGRID. A number of key algorithmic differences include
SLant’s use of consensus models, for both SSL and SDL interactions, and the use of a large
range of topological, community and GO features. SLant also treats node-wise features differ-
ently and includes the averaged difference between genes in a pair as well as the individual val-
ues for each gene. We show that the novel features present in SLant improve the results in the
feature holdout section (see Our pair-wise distance features are the most predictive) and pro-
pose that the different data sets appear to be providing a large impact on the results. A compar-
ison of the features used in the two studies are available in S7 Table.
Unfortunately, the source code for SINaTRA is not available. However we were able to
assess how our algorithm performed compared to SINaTRA, by testing it on the historical
yeast SSL data from BioGrid 3.2.104 that had been used in the development of the SINaTRA
algorithm. SINaTRA reports impressive AUC ROC values of 0.92 for in-species S. cerevisiae
SSL predictions, 0.93 for in-species S. pombe SSL predictions, 0.86 for S. cerevisiae to S. pombe
cross species validation and 0.74 for S. pombe to S. cerevisiae cross species validation. We
obtained similar results using cross validation (as reported by SINaTRA) with AUC ROC val-
ues of 0.98 for in-species S. cerevisiae SSL predictions, 0.98 for in-species S. pombe SSL predic-
tions, 0.88 for S. cerevisiae to S. pombe cross species validation and 0.77 for S. pombe to S.
cerevisiae cross species validation (see S8 Table).
Next, we re-implemented SINaTRA by running SLant with a close approximation of the
features that SINaTRA used originally but using the current STRING PPI network and current
SSL data for training (see S9 and S10 Tables). We found that SLant outperformed SINaTRA in
all tests apart from the S. pombe to S. cerevisiae cross species validation (AUC ROC 0.607 ver-
sus 0.609). In particular SLant considerably outperforms SINaTRA using models generated
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using the pair-wise non-bias segregated training sets. This supports our theory that the addi-
tional pairwise features incorporated into SLant leads to a generalisation of the models.
Finally we analysed the 2518 predicted human SSL pairs, with a SINaTRA score of over
0.90, that were published in the original paper. Of these, none of these predictions have subse-
quently been reported in BioGRID, either as SSLs or as negative genetic interactions. However,
the number of reported SSLs for humans is still rather low. Encouragingly, 55% of the SINa-
TRA high confidence SSL predictions were also predicted to be SSLs by SLant.
Slorth database
We employed the full cross-species consensus model to predict SSL and SDL gene pairs in all
of our species. All pairs that did not achieved a consensus score of over 0.75 were removed
from our final prediction list. All predictions are available in the Slorth database http://slorth.
biochem.sussex.ac.uk.
The graphical visualizations of the SSL predictions and the experimentally derived SSL
interactions from our training data (S4A Fig) shows that the SSL network becomes much
denser around the genes represented in the initial training data from BioGRID. This suggests
that genes already implicated in an SSL pairs may share more SSL interactions than currently
experimentally identified.
Predicting and validating SSL gene pairs associated with cancer
Using the models and classifiers described above we have identified and validated previously
unpublished human SSLs that could be exploited therapeutically in the treatment of cancer. To
identify potential therapeutic targets using our consensus method, we identified all the SSL
gene pairs in H. sapiens where one of the genes had been identified as a tumour suppressor by
the cancer gene census [56] (S4B Fig, appendix Table 4) and the other was a target of a drug
approved for human use.
We found an enrichment in highly scoring SSL pairs containing the tumour suppressors
VHL and PTEN. SSL pairs with the highest consensus scores included SREBF1, a transcription
factor that binds to sterol regulatory element-1 and VHL (confidence score 0.810) and PTEN
and SFN, a gene associated with breast cancer (confidence score 0.808). Other novel, highly
scoring gene pair predictions that included cancer associated genes included PARP1 with
PBRM1, BRCA2, ARID1A and APC as well as PIK3CA with MAP2K1, ABL1 and EGFR.
Validation on a handful of these predicted pairs providing some evidence that PBRM1 /
PARP1 and PBRM1 / ABL1 share previously undescribed SSL interactions. We also see some
evidence that PBRM1 / POLA1 share a synthetic rescue interaction.
Experimental validation of predictions
A set of predicted gene pairs, where one of the genes identified was PBRM1, was selected for
experimental validation. The PBRM1 gene codes for the tumour suppressor BAF180 a protein
that plays a key role in both chromatin remodelling and gene transcription. It is frequently
mutated in a subset of cancers including Clear Cell Papillary Renal Cell Carcinoma and Clear
Cell Renal Cell Carcinoma [57] We chose gene pairs where the second gene codes for a protein
which has published inhibitors. These included; PARP1, ERBB2, RAF1, POLA1, JAK2, ABL1,
GSK3B (S5 Table). Inhibitors were chosen and procured via Sellekchem (https://pubchem.
ncbi.nlm.nih.gov/source/Selleck%20Chemicals).
Clonogenic survival assays [58] were prepared for a control group and a BAF180 knockout
group from the U2OS cell line. Both cell groups were treated with a range of drug
Predicting SSLs using conserved patterns in PPI networks
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1006888 April 17, 2019 15 / 25
concentrations based on previous literature for each. The resulting cell colonies were stained
and counted after 14 days of incubation.
Of the drugs tested, three showed differential effects on the BAF180-deficient cells when
compared to the control cells. PBRM1 mutant cells were more sensitive to both the PARP
inhibitor and, to a lesser extent, ABL1 inhibitor than the control cells (Fig 5 with plate photog-
raphy in S5 Fig), whereas the PBRM1 mutant cells appeared less sensitive to the POLA1 inhibi-
tor than the control cells (Fig 5). Interestingly, cells lacking ARID1A, which is another SWI/
SNF subunit, are also selectively sensitive to PARP inhibitors [59, 60], which supports this rela-
tionship. We also note this ARID1A / PARP1 SSL interaction was not present in the BioGRID
data used to generate our training set but was also predicted with a high probability by SLant.
The two protein products of the two genes SSL with PBRM1; PARP1 and ABL1, share a num-
ber of similar cellular processes such as regulation of differentiation, proliferation and of DNA
damage and stress response. POLA1 which potentially shares a different type of interaction,
synthetic rescue, plays an essential role in the initiation of DNA replication.
Discussion
In this paper we have predicted SSL relationships using features derived from both in-species
and cross-species PPI network information. The SLant consensus classifier out-performs pre-
vious attempts at predicting human and model organism SSL interactions and may provide a
useful tool in guiding future experimental validation of SSL pairs.
The original intention in this study was to predict cross-species without using the target
species’ data in the training set. However our in-species predictions generally performed so
well it seemed sensible to instead use the additional cross-species data as an enhancement
instead. The only in-species classifier that underperformed was that derived for S. cerevisiae.
However, this result should be interpreted with caution; direct comparison of results is not
possible as there are differences in the validation data. So that others may compare their algo-
rithm to ours we have made all of the source code for SLant freely available so that our results,
training data and validation can easily be recreated and repeated.
Improving the quantity and the quality of the input data will also improve the quality of the
SSL and SDL predictions. For instance the amount of genetic interaction data is very limited
in humans and D. melanogaster. Protein-protein interaction data is plentiful for humans and
the model organisms studied, but the majority of the interactions are unlabelled. Adding addi-
tional annotation to these interactions, e.g. the direction of an interaction, may improve pre-
dictions if enough labelled data were available. Also, both the PPI and the genetic interactions
reported have ‘popularity bias’; genes and proteins of biological or medical interest are fre-
quently studied and hence more interactions involving them are reported.
Recently Abdollahpouri et al. [61] developed a flexible regularization-based framework
which can be used to control for popularity. An adaptation of this method to enhance the cov-
erage of less frequently reported genetic interations, may help mitigate this bias. Furthermore,
providing a reliability score for genetic interactions and only using the more reliable ones may
be particularly important for S. cerevisiae where although there is a wealth of data, the number
of false positives reported experimentally may be corrupting the prediction accuracy.
In an attempt to ascertain whether synthetic lethal interactions occurred within or between
local clusters of genes in our physical network we applied a spin glass random walk to assign
genes to distinct clustered communities separated by choke points across the graph. Analysis
showed that the majority of SSL interactions occurred between these communities rather than
within them. Based on the shorter distance between SSL genes and higher occurrence of adja-
cency presumably SSL genes are often at the peripheries of these communities. Further
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exploration of how SSL pairs are distributed between clustered communities such as these may
shed further light on the node wise features of genetic interactions.
Although this study does not use orthology data directly we do note that our GO annotation
features may in some way serve as a proxy for orthology data and this study could be also be
expanded in the future through improved analysis of the relationship between GO terms and
pairwise SSL pairs.
The identification of SSL interactions is a key step in expanding and improving targeted
cancer therapy. The results presented here suggest that inhibition of PARP1 or of ABL protein
kinase 1 may have therapeutic value in tumours lacking functional BAF180. The computa-
tional and experimental validation of our models performance presented in this study suggests
that the predictions provided by SLant, all of which have been made publicly available, will be
Fig 5. Carcinogenic survival assay results charting survival of PBRM1 / BAF180 knock-out cell lines with concentration
intervals of the PARP inhibitor Olaparib, the POLA inhibitor Erocalciferol and the ABL inhibitor Dasatanib. These results
suggest PBRM1 mutant cells may be more sensitive to both the PARP and ABL1 inhibitors while gaining some resistance to POLA1
inhibition. Error bars measure standard error of measurement. All drug intervals are measured in mM.
https://doi.org/10.1371/journal.pcbi.1006888.g005
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useful in guiding future SSL screening studies and ultimately in the continued goal of generat-
ing a more complete list of human SSL pairs.
Materials and methods
Data Acquisition and pre-processing
Gene and orthology data were downloaded from Ensembl [62], Genetic interaction data were
obtained from BioGRID (version 3.4.156) [42] with supplementary D. melanogaster data
downloaded from Flybase (version 6.13) [63]. Each gene was labelled with gene ontology (GO)
data from the gene ontology consortium [41]. Protein-protein interaction (PPI) data were
obtained from the STRING database (version 10) [39]. To ensure reliability only experimen-
tally derived and curated pathway data with a reliability cut-off of 80 were utilised (S6 Table).
The Ensembl ENSP protein IDs in the PPI data sets were converted to their respective Ensembl
ENSG gene IDs. This enabled us to relate the physical interaction data to the genetic interac-
tion data and label each physical interaction gene pair as SSL (if present in the BioGRID data)
or non-SSL (if the pair was not present in the BioGRID data).
For each organism an equal number of non-SSL pairs were assigned randomly to constitute
the negative training set. When assigning a non-SSL pair, we checked to makes sure that its
orthologues had not been assigned as having an SSL as, although it is not prescriptive, there is
an enrichment of SSL pairs in orthologous genes.
Similar methods were used to build the training set used for our SDL interaction classifiers
but we instead extracted BioGRID pairs annotated as synthetic dosage lethal as our positive
class data.
Feature processing
The R (version 3.4.0) igraph package (version 1.1.2) [40] was used to generate a network repre-
sentation of the PPI data for each of our 5 organisms and to calculate network features.
(Table 1). Whilst we extracted network features for just a subset of all possible gene pairs the
entire network of protein interactions was used in each calculation.
The features generated for our models were broadly categorised as node-wise or pairwise
features as listed in Table 1. In general node-wise features, such as degree, were calculated by
extracting network parameters for single nodes and finding the averaged distance between
them as a pairwise feature. Pairwise features such as shortest path were calculated by igraph on
each pair. To calculate shared GO terms, classed as a pairwise feature, we took a count of over-
lapping GO terms between the genes in each pair.
To generate our community features we applied a spin-glass random walk using the R
igraph communities module to assign genes to 20 distinct communities separated by choke
points across the graph. The final count of communities, 20, was chosen by measuring the pre-
dictive performance of our community features with a community count incrementing in
steps of 5. After 20 communities we saw no further improvement.
The entire feature generation pipeline for the full complement of available gene pairs
proved computationally intense, especially the generation of pairwise features such as cohe-
sion, and run-time took up to 120 hours for each organism on an 8x Intel Xeon 3.50GHz pro-
cessor with 16Gb RAM.
Training and test sets
Before analysis all features in each dataset were normalised so that all feature values fell
between 0 and 1. The resulting feature sets were divided into training, test and unlabelled sets.
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For each organism the feature set was under sampled to provide a balanced training set with
an equal number of SSL and non-SSL pairs. The training set was further partitioned 80:20 to
create a test set. The non-SSL pairs removed from the training data as part of under sampling
were set aside as unlabelled data to be used in the prediction section of this study.
Creating balanced training and test pair sets with distinct gene components
Some genes are highly represented in our available SSL training data whilst some only occur
once, so generating two sets with balanced classes and a requisite number of observations
posed a challenge. To create balanced training and test datasets with enough observations to
perform validation we first created a list of genes ranked by the number of pairs they were
found in. Next we divided this list adding the first to our list of genes available in our training
data, the second to our test data and so on so that both data sets had a similar distribution of
gene representation. Finally we used these two gene lists to filter our feature data into two sub-
sets with no overlapping genes and balanced class.
Analysis and modelling
We used the “ranger” e1071 random forest classifier, part of the R caret library, to model and
classify SSL and non-SSL interactions in our training set. 5-fold cross validation was applied to
each organism’s training set to tune the model’s hyper-parameters and the best model was
used to assess predictive performance within each species. These optimised models were then
used to predict SSL pairs across species, both in H. sapiens and across all other model organ-
isms. These predictions were outputted as the probability of each class and were validated
against the test data set.
Calculating cross species consensus
In an attempt to further improve accuracy, as well as pairwise cross-species predictions, a con-
sensus was taken from the predictions on the test set from all other species. This consensus
was calculated by running a second classifier, a boosted Generalized Linear Model (GLM) that
was trained on the previous classifiers outputs. To allow for validation this consensus dataset
was segmented into a train and test set (both 0.5 the size of the original due to the smaller over-
all size). Finally we used this consensus model to predict SSL pairs in the unlabelled data set.
All of the R source code for SLant is available publically at https://bitbucket.org/
bioinformatics_lab_sussex/slant. All data used is available via public resources.
Validation using clonogenic survival assays
A subset of potential SSL interacting pairs featuring PBRM1 (BAF180) complemented with
genes with a known inhibitor were chosen from our predictions for experimental validation
(S5 Table).
Cell culture. U2OS-derived control and PBRM1-deficient cell lines [64] were cultured in
Dulbecco DMEM supplemented with 10% FBS, glutamine and Penicilin/Streptomycin.
Clonogenic survival assays. Cells were seeded and allowed to adhere prior to drug treat-
ment. Cells were exposed to the indicated amount of drug in triplicate, and incubated for 14
days at 37C with 5% CO2 prior to staining with methylene blue ((0.4%). Cell colonies were
manually counted and presented as the surviving fraction relative to the untreated cells.
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Supporting information
S1 Fig. Feature distributions. a. A distribution of normalised adhesion scores for each organ-
ism illustrate significant differences in SSL and non-SSL pairs across species. b. A normalised
shortest path distribution shows a general trend for shorter shortest paths between H. sapiens
SSL pairs though this difference is less pronounced in our model organisms. c. A distribution
of normalised mutual neighbour counts suggests that SSL pairs often share more mutual
neighbours than non-SSL pairs.
(TIFF)
S2 Fig. GO terms. Count of most common associations between molecular function GO
terms observed in SSL pairs. Individual feature GO associations extracted from full GO anno-
tation lists for each SSL gene pair.
(TIF)
S3 Fig. Feature value distributions. Violin plots illustrating feature value distributions for A,
S. cerevisiae, B, C. elegans, C, D. melanogaster and D, S. pombe.
(TIFF)
S4 Fig. SSL interaction networks. a. Full SSL interaction network of predicted human SSL
pairs shaded by likelihood of being a true SSL pair based on consensus score. Red edges are
interactions sourced from our training data (directly from BioGRID) lighter edges denote a
lower consensus scores. Produced with Gephi 0.9.1 [8]. b. Network of SSL interaction predic-
tions with high consensus scores associated with known tumour suppressors including, where
available, VHL, BRCA1, BRCA2, PBRM1, PTEN and APC.
(TIFF)
S5 Fig. Survival assay plate images. Survival assay plate images for ABL inhibitor Dasatanib
(marked as Dasat) (A, B, C & D) and POLA inhibitor Erocalciferol (marked as VD2, an abbre-
viation of vitamin D2) experiments (E, F, G & H). BAF180 knock-out cell-line plate images for
the PARP1 inhibitor Olaparib BAF180 are labeled with BAF and control plates marked with
NSC on plate lids and the corresponding plate colonies are displayed adjacent to each lid (I &
J).
(TIFF)
S1 References.
(DOCX)
S1 Table. Distribution of shared molecular function, biological process and cellular com-
partment GO terms that occur between SSL and non-SSL pairs. Data is shown for A, H.
sapiens, B, S. cerevisiae, C, C. elegans, D, D. melanogaster, and E, S. pombe. We observe that in
humans SSL pairs share significantly more molecular function and cellular compartment GO
terms while non-SSL pairs share significantly more biological process terms. A welch 2 sample
t-test was used to measure significance for each annotation. 2.2e-16 was the smallest value
available.
(DOCX)
S2 Table. Key features. This table contains a list of most important features for each species
reported via the R caret libraries random forest classifier. Feature importance rankings were
calculated by measuring the mean decrease in accuracy without each variable across all tree
permutations in the random forest.
(DOCX)
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S3 Table. Cross validation ROC AUC scores for S. cerevisiae and H. sapiens SDL models.
The best score for each species model is highlighted in green. Consensus model results are
highlighted in blue.
(DOCX)
S4 Table. Top 20 SSL predictions featuring common tumour suppressor genes.
(DOCX)
S5 Table. Genes SSL with BAF180. We chose a group of genes with selective inhibitors that
were predicted to share a synthetic lethal interaction with BAF180 (PBRM1) for validation.
We performed clonogenic survival assays for each inhibitor using U2OS cell lines (shControl
+ mCherry/NLS and shBAF180 + GFP/NLS).
(DOCX)
S6 Table. Number of protein-protein interactions used to generate the protein interaction
networks for each organism. Number of SSL pairs and SDL pairs sourced for each organism
from BioGRID after filtering for distinct pairs that inlcude genes present in the protein interac-
tion network. The SSL pair data for S. cerevisiae were filtered to include only interactions cited
in 3 or more papers. SSL pair data for S. pombe were filtered to include only interactions
recorded in 2 or more papers.
(DOCX)
S7 Table. A comparison of the features used by SLant and SINaTRA. SLant also treats
node-wise features differently by providing an averaged difference between node pairs as well
as the individual values per gene node.
(DOCX)
S8 Table. A comparison of SLant and SINaTRA AUC ROC scores using SSLs from Bio-
GRID 3.2.104. SLant data were generated in house, SINaTRA scores were extracted from
Jakunski et al., 2015 publication.
(DOCX)
S9 Table. A comparison of classification performance. AUC ROC scores from the SLant fea-
ture set versus the SINaTRA feature set using the full current training sets and the pairwise
non-bias data sets.
(DOCX)
S10 Table. A comparison of classification performance. A comparison of human SSL classi-
fication using the SLant consensus set versus the SINaTRA feature set using current data.
(DOCX)
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